Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
I read the study performed by Reinisch and colleagues with interest.1 As the authors state, the optimum strategy for the treatment of Crohn's disease following intestinal resection remains uncertain, with conflicting evidence for use of mesalazine,2 3 and only limited data to suggest that 6-mercaptopurine (6-MP) or azathioprine are more effective than placebo4 5 in terms of the prevention of either clinical or endoscopic relapse of disease activity.
Reinisch et al are therefore …
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.